Stay updated on Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-22T08:57:14.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-08T01:55:10.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Plain Language Summary added to the Study Details page. The update also lists recent change dates (2026-02-17, 2026-02, 2026-02-19) alongside the new content.
    Difference
    0.1%
    Check dated 2026-02-21T11:04:49.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.4.1 to v3.4.2; this is a minor metadata update with no user-facing impact. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T08:57:31.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added in place of v3.4.0. No other changes to page content are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-07T05:51:31.000Z thumbnail image
  9. Check
    76 days ago
    Change Detected
    Summary
    Adds a Show glossary option and a new revision label (v3.4.0) to the page, and normalizes capitalization for FEAR Act-related text. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-24T01:32:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial page.